By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


FORUM Pharmaceuticals (Formerly Known As EnVivo Pharmaceuticals, Inc.) 

225 Second Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 617-225-4250 Fax: 617-225-4267


Drug Discovery

Company News
FORUM Pharma Announces Removal Of Partial Clinical Hold On Phase III Encenicline Program For Cognitive Impairment In Schizophrenia 11/11/2015 10:52:50 AM
FORUM Pharma Halts Clinical Trials for Alzheimer’s and Schizophrenia Drug 9/15/2015 8:11:49 AM
FORUM Pharma Announces Publication Of Encenicline Phase II Clinical Trial Results For Cognitive Impairment In Schizophrenia 7/15/2015 9:46:53 AM
FORUM Pharma Snags Fast Track Status for Encenicline to Treat Cognitive Impairment in Schizophrenia 6/22/2015 6:45:36 AM
FORUM Pharma Announces Presentations At Upcoming Industry And Investor Conferences 6/10/2015 10:53:42 AM
FORUM Pharma Consolidates Operations in Anticipation of New Growth 5/18/2015 6:46:18 AM
FORUM Pharmaceuticals To Participate In Needham & Company’s 14th Annual Healthcare Conference 4/8/2015 10:03:43 AM
FORUM Pharmaceuticals To Participate In Suntrust Robinson Humphrey 2015 Biotechnology And Pharmaceutical Orphan Drug Day 2/18/2015 1:55:36 PM
FORUM Pharmaceuticals To Present At Leerink Global Healthcare Conference 2/11/2015 12:51:15 PM
FORUM Pharmaceuticals Initiates Phase 2a Clinical Trial Of FRM-0334 In Frontotemporal Dementia With GRN Mutation 2/10/2015 10:41:43 AM